SynthesisNeurosurgical review2026
Resection of brain radionecrosis after stereotactic radiosurgery or radiotherapy: a meta-analysis.
Synthesis in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBrain radionecrosis, a late-stage adverse effect of radiotherapy, presents diagnostic and treatment challenges. Although reports on its surgical resection have increased, no systematic review has thoroughly evaluated its clinical outcomes.
objectiveTo assess post-operative neurological improvement, overall survival, and complications following resection of brain radionecrosis.
methodsA search of PubMed, Embase, and the Cochrane Library was conducted following PRISMA principles (inception–February 2025). DerSimonian and Laird random-effects models were used to estimate pooled incidence with 95% confidence intervals (CIs).
resultsEight retrospective case series involving 443 patients, predominantly with high-grade gliomas and brain metastases, met the inclusion criteria. Neurological improvement was observed in 80.7% of patients (95%CI, 66.8%–89.6%). Survival outcomes were reported heterogeneously across studies. Only two studies provided overall survival (OS) from the time of resection in histopathology-confirmed pure radionecrosis cohorts; in these, pooled 12-month and 24-month OS were 84.6% (95%CI, 65.4%–94.1%) and 73.1% (95%CI, 53.3%–86.6%), respectively. The pooled incidence of postoperative complications was 21.4% (95%CI, 11.7%–35.9%), with most complications being transient and non-life-threatening, indicating an overall favorable safety profile.
conclusionSurgical resection for brain radionecrosis appeared to provide meaningful clinical benefit, with high rates of neurological improvement and an acceptable incidence of postoperative complications. Although survival outcomes were reported inconsistently and with varying time origins, available data suggest that selected patients may experience favorable short-term survival following surgery. Standardized definitions of radionecrosis and uniform reporting of survival from the time of resection are needed to strengthen the evidence base and guide clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.